ACHC · Acadia Healthcare Company, Inc.
Market Cap
$2.59B
Shares
92.21M
ACHC metrics
76 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$28.13
Market cap
$2.59B
Price action
19 metricsPrice change (1W)
-1.5%
Price change (30D)
-11.5%
Price change (3M)
+14.9%
Price change (6M)
+9.8%
Price change (YTD)
+98.2%
Price change (1Y)
+18.9%
Trailing year
Price change (5Y)
-58.7%
52-week high
$35.61
52-week low
$11.68
Change from 52-week high
-21.0%
Change from 52-week low
+140.8%
Annualized volatility
67.2%
Beta
0.9
RSI (14D)
44.7
Price vs SMA 50
-8.1%
Price vs SMA 200
+22.6%
Avg volume (3M)
2.66M
Relative volume
0.3
Average dollar volume
$77.71M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
92.21M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.5×
reciprocal yield 67.9%
EV / EBITDA
8.7×
reciprocal yield 11.5%
EV / EBIT
9.7×
reciprocal yield 10.3%
P / sales
0.8×
reciprocal yield 130.0%
P / book
1.3
reciprocal yield 75.5%
FCF yield
-11.2%
TTM · current market cap
Buyback yield
1.9%
P / FCF
—
P / operating cash flow
14.3
reciprocal yield 7.0%
Earnings yield
-42.7%
Historical valuation
8 metricsP / E historical average (3Y)
18.9×
reciprocal yield 5.3%
P / E historical average (5Y)
21.6×
reciprocal yield 4.6%
EV / revenue historical average (3Y)
2.1×
reciprocal yield 47.9%
EV / revenue historical average (5Y)
2.5×
reciprocal yield 39.2%
EV / EBIT historical average (3Y)
10.4×
reciprocal yield 9.6%
EV / EBIT historical average (5Y)
10.4×
reciprocal yield 9.6%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-29
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
-32.8%
Gross profit (TTM)
—
Operating profit (TTM)
$582.73M
Net income (TTM)
−$1.11B
Trailing 12 months
Diluted EPS (TTM)
$-12.20
FCF margin
-8.7%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+7.6%
Year over year
Net income growth YoY
-51.0%
Revenue (TTM)
$3.37B
Trailing 12 months
EPS growth YoY
-44.4%
Shares change YoY
-1.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+8.3%
Revenue CAGR (5Y)
+9.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-56.5%
Return on assets
-20.0%
Debt / equity
1.3
Current ratio
1.7
EBITDA (TTM)
$652.91M
Free cash flow (TTM)
−$291.79M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
4.7
Return on invested capital
—
Trailing 12 months
Net cash
−$2.37B
Latest balance sheet
Cash & equivalents
$158.47M
Total assets
$5.55B
Total debt
$2.53B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$181.95M
Capital expenditures (TTM)
$473.74M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$30.99M
R&D / revenue
—
Stock compensation / revenue
0.9%
Ownership (13F)
3 metrics13F filers
317
13F filer change QoQ
+17
Institutional ownership
147.1%
Short interest
3 metricsShort interest
22.7%
Latest settlement · 12.5 days to cover
Days to cover
12.5d
Short-squeeze score
74 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—